HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Branchiootic Syndrome 2

Also Known As:

BO Syndrome 2; BOS2

Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 933
- Congenital Abnormalities: 25723
  - Multiple Abnormalities: 211
    - Branchio-Oto-Renal Syndrome: 46
      - Branchiootic Syndrome 2: 5
  - Chromosome Disorders: 136
    - Branchio-Oto-Renal Syndrome: 46
      - Branchiootic Syndrome 2: 5
- Inborn Genetic Diseases: 11939
  - Chromosome Disorders: 136
    - Branchio-Oto-Renal Syndrome: 46
      - Branchiootic Syndrome 2: 5

Related Diseases

1.	Branchiootic syndrome
2.	Branchiootic Syndrome 3

Experts

1.	Jia, Xu: 1 article (02/2019)
2.	Leng, Xin: 1 article (02/2019)
3.	Long, Ying: 1 article (02/2019)
4.	Qiao, Chengfang: 1 article (02/2019)
5.	Xu, Wenfeng: 1 article (02/2019)
6.	Yang, Bingqin: 1 article (02/2019)
7.	Breckpot, Jeroen: 1 article (11/2009)
8.	Devriendt, Koen: 1 article (11/2009)
9.	Dimitriadou, Eftychia: 1 article (11/2009)
10.	Fryssira, Helen: 1 article (11/2009)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Branchiootic Syndrome 2:

1.	Transforming Growth Factor beta1 (TGF beta 1)IBA 11/01/2006 - "In the cohort, 78 subjects, with an overall mean +/- SE survival 2,339 +/- 117 days, had no correlation between onset of BOS1, BOS2 or survival with TNF-alpha, IFN-gamma, TGF-beta1 or IL-10 gene polymorphisms. "
2.	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 11/01/2004 - "The Pathogenesis Related gene 1 (PR-1), a molecular marker of the salicylic acid (SA)-dependent resistance pathway, shows a wild-type pattern of expression in bos2, while in bos3 this gene was expressed at elevated levels, both constitutively and in response to pathogen challenge. "
3.	Interleukin-10 (Interleukin 10)IBA 11/01/2006 - "In the cohort, 78 subjects, with an overall mean +/- SE survival 2,339 +/- 117 days, had no correlation between onset of BOS1, BOS2 or survival with TNF-alpha, IFN-gamma, TGF-beta1 or IL-10 gene polymorphisms. "
4.	Interleukin-6 (Interleukin 6)IBA 11/01/2006 - "A second cohort of more recent lung transplant recipients did not validate an association between IL-6 polymorphisms and earlier onset of BOS1 (p = 0.70), BOS2 (p = 0.54) or overall post-transplant survival (p = 0.25). " 11/01/2006 - "However, IL-6 polymorphisms GG or GC were associated with an earlier onset of BOS1 (p = 0.039), BOS2 (p = 0.021), and decreased overall post-transplant survival (p = 0.038). "
5.	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/01/2006 - "In the cohort, 78 subjects, with an overall mean +/- SE survival 2,339 +/- 117 days, had no correlation between onset of BOS1, BOS2 or survival with TNF-alpha, IFN-gamma, TGF-beta1 or IL-10 gene polymorphisms. "
6.	RhodaminesIBA 02/18/2019 - "Two rhodamine B-based fluorescent probes, BOS1 and BOS2, were designed and synthesized with good yields via the condensation reactions between the o-diaminobenzene modified rhodamine core structure (RBO) and salicylaldehyde derivatives. "
7.	Proteins (Proteins, Gene)FDA Link 11/01/2009 - "Mapping of the deletion breakpoints allowed to delineate the region involved in BOS2 to a 5.25 Mb region containing 27 protein-coding genes. "
8.	Fluorescent Dyes (Fluorescent Probes)IBA 02/18/2019 - "Two rhodamine B-based fluorescent probes, BOS1 and BOS2, were designed and synthesized with good yields via the condensation reactions between the o-diaminobenzene modified rhodamine core structure (RBO) and salicylaldehyde derivatives. "
9.	BoronIBA 04/01/1997 - "In addition to the resonances from boron in two types of BS3 groups, four other structural units, BOS2, BO2S, BO3 and BS4, were elucidated from the spectra of vitreous and crystalline samples. "
10.	camalexinIBA 11/01/2004 - "The bos2 and bos4 mutants accumulate reduced levels of camalexin whereas bos3 accumulates significantly higher levels of camalexin than wild-type plants in response to B. " 11/01/2004 - "The BOS2, BOS3, and BOS4 loci may affect camalexin levels and responsiveness to ethylene and jasmonate. "